World Journal of Pharmaceutical
Science and Research

An International Peer Reviewed Journal for Science & Pharmacy Professional


Login | Registration


ISSN: 2583-6579


Impact Factor: 5.111

ABSTRACT

EVALUATING THE SAFETY OF EVOLOCUMAB IN CARDIOVASCULAR DISEASE

Gokul S.* and Dr. P. Rama

Evolocumab is a ground breaking monoclonal antibody that plays a crucial role in managing cardiovascular disease by targeting PCSK9, a protein involved in cholesterol regulation. By inhibiting PCSK9, evolocumab enhances the liver's ability to clear LDL cholesterol, effectively reducing cardiovascular events. This powerful LDL-lowering mechanism is especially advantageous for patients with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD) who do not respond well to standard treatments. Clinical studies, such as the FOURIER trial, have shown that evolocumab can lower LDL cholesterol by 50-60% and decrease cardiovascular events by 15%. Despite current therapies, residual cardiovascular risk persists, underscoring the need for additional treatments. Evolocumab fills this gap as a valuable complement to statin therapy. Its safety and efficacy, confirmed by extensive clinical trials, make it a reliable option for a wide range of patients. Incorporating evolocumab into clinical practice represents a major advancement in reducing cardiovascular risk, enhancing patient outcomes, and improving the quality of life for high-risk individuals not adequately managed by conventional lipid-lowering therapies.

[Full Text Article]

TRACK ARTICLE

NEWS

  • Impact Factor Increased

    We are pleased to inform you that our IMPACT FACTOR has increased from 3.454 to 5.111

    Email & SMS Alert

    We will provide you email alerts regarding New Issue Release, Publication of your Article, Invitaion for New Upcoming Issue, Manuscript releted Emails etc.

    August 2024 Issue Published

    Its Our pleasure to inform you that, WJPSR August 2024 Issue has been Published, Kindly check it on Click here

    Indexing

    This journal is indexed in world wide reputed commettee like: "DOI for all Articles" "Google Scholer" "SJIF Impact Factor:- 5.111" "Cosmos Impact Factor" "ISI Indexing" "International Impact Factor Services (IIFS)" "ResearchBib" etc.

    Article Invite for Publication

    Dear Researcher, Article Invited for Publication  in WJPSR Coming Issue.

    If you wish to Publish your Article in WJPSR Coming" August 2024 " Issue, 

    Submit it as soon as possible.